---
title: "IPO News: What to look for when Lumexa Imaging goes public"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/269101621.md"
description: "Lumexa Imaging Holdings plans to go public, offering 25 million shares priced between $17-$20 each, aiming to raise $427 million. The IPO will be listed on Nasdaq under the symbol LMRI, managed by Barclays, JP Morgan, and Jefferies. Proceeds will repay debt and fund working capital. Lumexa reported $755.3 million in revenue for nine months ending September 2025, with a net loss of $18.4 million, an improvement from the previous year."
datetime: "2025-12-09T13:48:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/269101621.md)
  - [en](https://longbridge.com/en/news/269101621.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/269101621.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/269101621.md) | [English](https://longbridge.com/en/news/269101621.md)


# IPO News: What to look for when Lumexa Imaging goes public

IPO activity rebounded in the second half of the year, with the technology and healthcare sectors maintaining their dominance in public listings. The recovery has been supported by lower interest rates and a strong equity market. Lumexa Imaging Holdings, an operator of outpatient medical scanning centers, is the latest healthcare firm to pursue an initial public offering. In a recent filing with the Securities and Exchange Commission, the company revealed plans to offer around 25 million shares, priced between $17.0 per share and $20.0 per share.

## The Offering

Lumexa has applied to list on the Nasdaq stock exchange under the symbol _LMRI_. The group of underwriters managing the offering is led by Barclays, JP Morgan, and Jefferies. **The stock offering is expected to generate proceeds of around $427.0 million – after deducting charges – at the midpoint of the estimated price range**. The management intends to use the proceeds to repay a portion of the company’s outstanding debt and for working capital. With around 94.6 million shares expected to be outstanding post-IPO, the company targets a valuation of up to $1.89 billion.

**_Also Read:_ Costco Q1 FY26 Earnings Preview**

For the nine months ended September 30, 2025, Lumexa reported total revenues of $755.3 million, compared to $700.8 million in the corresponding period last year. The company posted a net loss of $18.4 million for the nine months, an improvement from the prior-year period when it incurred a loss of $69.0 million. Income from operations more than doubled to $83.6 million during the period.

## The Business

Lumexa is a leading provider of advanced diagnostics like MRI, CT, and mammography in the US through a large network. Founded in 2018, the company is currently led by chief executive officer Caitlin Zulla. **Since its inception, Lumexa has completed 20 acquisitions and opened 41 _de novo_ centers, which are modern, company-owned, standalone outpatient imaging facilities.** It is estimated that the _diagnostic imaging services_ market grew at a compound annual rate of 4.2% from 2019 to 2024, led by freestanding imaging center growth of 6.9%.

The post IPO News: What to look for when Lumexa Imaging goes public first appeared on AlphaStreet.

### 相關股票

- [Barclays (BARC.UK)](https://longbridge.com/zh-HK/quote/BARC.UK.md)
- [Nasdaq (NDAQ.US)](https://longbridge.com/zh-HK/quote/NDAQ.US.md)

## 相關資訊與研究

- [11:37 ETWaste Pro USA, Inc. Announces the Reoffering of $120.0 million of Solid Waste Disposal Revenue Bonds](https://longbridge.com/zh-HK/news/281550104.md)
- [Barclays upgrades Ørsted to Equal Weight (Underweight), price target set at DKK 160 - BN](https://longbridge.com/zh-HK/news/281301318.md)
- [SpaceX Eyes IPO Valuation of Over $2 Trillion](https://longbridge.com/zh-HK/news/281578787.md)
- [TK Elevator keeps IPO option on the table](https://longbridge.com/zh-HK/news/281135641.md)
- [KPET Ultra Paceline Corporation Announces Pricing of Initial Public Offering | KPET Stock News](https://longbridge.com/zh-HK/news/281076881.md)